View Author
dai: 074702459
scopus: 7006475540
Hofland, L.J.
(Leo Hofland)Supervisor (promotor) of 2 dissertations
receptor somatostatin tumor effect expression patient treatment study level subtype octreotide growth insulin ghrelin secretion endocrinol hormone adenomas sst 2 igf-i control cancer endocrinology analogue binding metab journal therapy disease concentration analog release sst 5 lambert tissue culture cushing dopamine som 230 adenoma result corticotroph inhibition response somatostatin receptors glucose tumor cells signi group cortisol agonist tumour system sst subtypes value factor van koetsveld pm activity administration corticotroph adenomas somatostatin receptor subtypes serum igf-i bioactivity activation pancreatic carcinoma number syndrome adhesion table surgery protein medium peptide experiment regulation growth hormone cabergoline increase acromegaly
10 Most Recent Publications
|
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells
(Article)
Vitale, G. Zappavigna, S. Piccoletti, R. Koetsveld, P.M. van Cavagnini, F. Budillon, A.M. Abbruzzese, A. Hofland, L.J. Caraglia, M. Marra, M. Dicitore, A. Meschini, S. Condello, M. Arancia, G. Castiglioni, S. Maroni, P. Bendinelli, P. |
2012-01-01
|
|
The role of somatostatin and dopamine D
2 receptors in endocrine tumors
(Article)
Gatto, F. Hofland, L.J. |
2011-12-01
|
|
Type i interferons as radiosensitisers for pancreatic cancer
(Article)
Morak, M.J.M. Koetsveld, P.M. van Kanaar, R. Hofland, L.J. Eijck, C.H.J. van |
2011-09-01
|
|
IGF-I bioactivity better reflects growth hormone deficiency than total IGF-I
(Article)
Varewijck, A.J. Lamberts, S.W.J. Uitterlinden, P. Hofland, L.J. Janssen, J.A.M.J.L. |
2011-07-01
|
|
Effects of interferons α/β on the proliferation of human micro- and macrovascular endothelial cells
(Article)
Erdmann, J. Vitale, G. Koetsveld, P.M. van Croze, E. Sprij-Mooij, D. Hofland, L.J. Eijck, C.H.J. van |
2011-05-01
|
|
Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis
(Article)
Al-Azzawi, H. Yacqub-Usman, K. Richardson, A. Hofland, L.J. Clayton, R.N. Farrell, W.E. |
2011-02-01
|
|
Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir
(Article)
Varewijck, A.J. Goudzwaart, J.A. Brugts, M.P. Lamberts, S.W.J. Hofland, L.J. Janssen, J.A.M.J.L. |
2010-12-01
|
|
Temozolomide-induced shrinkage of a pituitary carcinoma causing cushing's disease - Report of a case and literature review
(Article)
Curtò, L. Torre, M.L. Ferrau, F. Pitini, V. Altavilla, G. Granata, F. Longo, M. Hofland, L.J. Trimarchi, F. Cannavò, S. |
2010-11-04
|
|
Pituitary tumours: The sst/D2 receptors as molecular targets
(Article)
Hofland, L.J. Feelders, R.A. Herder, W.W. de Lamberts, S.W.J. |
2010-09-01
|
|
Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells
(Article)
Hofland, L.J. Lamberts, S.W.J. Feelders, R.A. |
2010-09-01
|
